Clinical Trial Update: A Tolerability and Efficacy Study of TU-100 For The Treatment of Postoperative Ileus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TU-100 for postoperative ileus has completed, with tolerability and efficacy assessments reported. The update provides status and high-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Ileus

Drugs mentioned

• TU-100 (Daikenchuto)

Snippet

Sponsor: Tsumura USA | Conditions: Postoperative Ileus | Phase 2 | Status: COMPLETED